IQP-VV-102

· InQpharm Group

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IQP-VV-102, covering 2015-11-06 to 2015-11-10. Get the full timeline:

Most recent: Clinical Trial Update: Benefit of IQP-VV-102 in Reducing Postprandial Glucose Level in Overweight Caucasian Subjects [Phase 3]